Physician profile
Christopher Peter Houk
NPI 1194760777
$1,638.51
in general payments reported to CMS, 2019-2025
22 companies · $300 in 2025
The $300 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $86.97 · 2021: $227 · 2022: $359 · 2023: $231 · 2024: $215 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $343.97 | 2021-2024 | |
| Pfizer INC. | $296.06 | 2019-2025 | |
| Dexcom, INC. | $257.44 | 2019-2025 | Dexcom G6 Transmitter |
| Ascendis Pharma Endocrinology INC | $123.08 | 2022-2025 | Skytrofa |
| Abbott Laboratories | $69.52 | 2021-2025 | |
| Medtronic, INC. | $67.33 | 2021 | |
| Insulet Corporation | $66.27 | 2019-2023 | Omnipod |
| Ultragenyx Pharmaceutical INC. | $62.34 | 2022 | |
| Beta Bionics, INC. | $38.14 | 2024 | Ilet Bionic Pancreas |
| Tandem Diabetes Care, INC. | $38.10 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Becton, Dickinson and Company | $37.12 | 2019 | |
| Neurocrine Biosciences, INC. | $35.44 | 2025 | |
| Xeris Pharmaceuticals, INC. | $29.39 | 2021-2022 | |
| Kyowa Kirin, INC. | $26.89 | 2023 | Crysvita |
| Sanofi-Aventis U.S. LLC | $24.98 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rhythm Pharmaceuticals, INC. | $22.47 | 2022 | |
| Sequel Med Tech, LLC | $20.76 | 2025 | Twiist |
| Embecta Corp. | $20.45 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Novo Nordisk INC | $20.27 | 2019 | |
| Endo Pharmaceuticals INC. | $16.70 | 2021 | |
| Senseonics, Incorporated | $11.00 | 2020 | |
| Medtronic Minimed, INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Houk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.